With regards to CEP290, we could target a PTM downstream of cryptic exon X. This approach could ultimately correct at least one allele in nearly 70% of LCA10 patients and approximately 50% of all reported loci with mutations within CEP290. This evidence concerns the gene CEP290 and Leber congenital amaurosis 10.